Association between IgM anticardiolipin antibodies and deep venous thrombosis in patients without systemic lupus erythematosus

Abstract

Patients with systemic lupus erythematosus (SLE) are at risk of developing deep venous thrombosis (DVT). Should anticardiolipin antibodies (aCL) be detectable, this risk is significantly raised, particularly when these autoanti-bodies are cofactor-dependent. We conducted a cross-sectional study of consecutive unselected outpatients referred for clinical suspicion of DVT, as an attempt to address the following questions: firstly, were aCL antibodies associated with DVT in non-SLE patients? Secondly, was this association related to the cofactor dependence? From March 1992 to February 1994, 208 patients were enrolled in the study. Venography was positive in 110 patients (DVT patients), while the diagnosis of DVT could not be confirmed in the remaining 98 (referred to as disease controls). ACL was measured by ELISA, for IgG and IgM isotypes in two ways: fetal calf serum or bovine serum albumin were used as blocking agents to distinguish between cofactor- dependent and cofactor-independent antibodies. Positive aCL was defined as optical density (OD) values greater than the 95th percentile of OD distribution of 60 healthy controls. We found a high frequency of positive IgG aCL antibodies in both DVT patients and in disease controls (25.5 vs 23.5%). We suggest an association between IgM aCL and DVT. This association was, however, not dependent on the cofactor requirement.

Keywords

anticardiolipin antibodies thrombosis vein

Get full access to this article

View all access options for this article.

References

Alarcon-Segovia D. et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine 1989 ; 68(6): 353-365.

Triplett DA Protean clinical presentation of antiphospholipid-protein antibodies (APA) . Thromb Haemost 1995; 74: 329-337.

Petri M. Diagnosis of antiphospholipid antibodies. Rheum Dis Clin North Am 1994; 20: 443-469.

Brighton TA , Chesterman CN

Antiphospholipid antibodies and thrombosis. Baillière's

Clin Haematol 1994; 7: 541-557.

Manoussakis MN et al. High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population. Clin Exp Immunol 1987; 69: 557-565.

Hughes Grv. The antiphospholipid syndrome: ten years on. Lancet 1993; 342: 341-344.

Canoso RT , De Oliveira RM Chlorpromazine-induced anticardiolipin antibodies and lupus anticoagulant: absence of thrombosis. Am J Haematol 1988; 27: 272-275.

Love PE , Santoro SA Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med 1990 ; 112: 682-698.

Ginsburg KS et al. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med 1992 ; 117: 997-1002.

10.

Ginsberg JS et al. Antiphospholipid antibodies and venous thromboembolism. Blood 1995; 86: 3685-3691.

11.

Bongard O. , Reber G. , Bounameaux H. , De Moerloose P. Anticardiolipin antibodies in acute venous thromboembolism. Thromb Haemost 1992; 67: 724.

12.

McNeil HP , Simpson RJ , Chesterman CN , Krilis SA Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87: 4120-4124.

13.

Galli M. et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990 ; 335: 1544-1547.

14.

Pengo V. , Biasiolo A. , Fior MG Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when β2-glycoprotein I is bound to a suitable surface. Thromb Haemost 1995; 73: 29-34.

15.

Cabral AR , Cabiedes J. , Alarcon-Segovia D. , Sanchez-Guerrero J. Phospholipid specificity and requirement of β2-glycoprotein-I for reactivity of antibodies from patients with primary antiphospholipid syndrome . J Autoimmun 1992; 5: 787-801.

16.

Viard JP , Amoura Z. , Back JF Anti-β2-glycoprotein-I antibodies in systemic lupus erythematosus — a marker of thrombosis associated with lupus anticoagulant activity. CR Acad Sci [III] 1991; 313: 607-612.

17.

Manoussakis MN et al. High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population. Clin Exp Immunol 1987; 69: 557-565.

18.

Matsura E. et al. Heterogeneity of anticardiolipin antibodies defined by anticardiolipin cofactor. J Immunol 1992; 148: 3885-3891.

19.

Sugi T. , McIntyre JA. Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex. Blood 1995; 86: 3083-3089.

20.

Bevers EM et al. Lupus anti-coagulant IgG's (LA) are not directed to phospholipids, but to a complex of lipid-bound human prothrombin. Thromb Haemost 1991; 66: 629-632.